NSC |
Compound |
Enrichment |
Correlation |
NSC 719667 |
7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one |
0.0392716453377535 |
-0.070253622 |
NSC 726217 |
Combretastatin A4-analogue |
0.0392716453377535 |
0.29570357 |
NSC 732936 |
5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.0392716453377535 |
0.22483855 |
NSC 734949 |
4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide |
0.0392716453377535 |
0.10316857 |
NSC 743433 |
8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one |
0.0392716453377535 |
0.07523534 |
NSC 748147 |
5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide |
0.0392716453377535 |
0.12354394 |
NSC 748902 |
[(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] |
0.0392716453377535 |
0.24084605 |
NSC 752506 |
5-nitro-N-((pyridin-3-yl)methyl)furan-2-carboxamide |
0.0392716453377535 |
0.2910138 |
NSC 753377 |
3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine |
0.0392716453377535 |
0.26721279 |
NSC 753598 |
Null |
0.0392716453377535 |
0.02021269 |